Although cancer is the second leading cause of death in this country, there are more than 15 million cancer survivors currently living here in the United States. And while numerous cancer treatment options are available, they can be painful, draining, and leave people transformed in multiple ways. Many people can go on to live normal and healthy lives after battling cancer. However, a growing number of patients are experiencing permanent changes as a result of a chemotherapy drug called Taxotere.
Cancer survivors are claiming that Taxotere caused permanent and unexpected hair loss, and they are taking the makers of Taxotere to court for failing to warn them of unexpected side effects, misleading the public with false advertising, and marketing a dangerous drug.
Broughton Partners provides a legal case generation service that helps personal injury attorneys find patients who have become victims of Taxotere side effects. We deliver pre-qualified leads with retained Taxotere plaintiffs. The Taxotere leads your law firm receives are case-ready and have been fully reviewed for lawsuit eligibility. If your law firm is looking to help more patients who have suffered permanent hair loss due to Taxotere, call Broughton Partners today and connect with Taxotere plaintiffs.
Taxotere Background Information
Taxotere is a chemotherapy drug that interferes with a cancer cell’s most basic functions.
Sometimes known as docetaxel, Taxotere is injected into a vein using an IV once every three weeks to inhibit a cell’s mitosis function. By interfering with cell division and replication, Taxotere helps to control and stop the spread of cancerous cells.
The drug was first approved by the U.S. Food and Drug Administration in 1999 to treat non-small cell lung cancer and for prostate cancer and breast cancer treatment in 2004. The drug also received approval for use in the treatment of stomach, head, and neck cancers in 2006. It is manufactured and marketed by Sanofi-Aventis.
Taxotere is currently one of the most popular breast cancer drugs on the market but is also used for cancer of the lung, stomach, head, neck, and prostate.
Most Common Taxotere Side Effects
Like many chemotherapy drugs, Taxotere has a number of side effects. According to its prescribing information sheet, Taxotere’s most common side effects include:
- Changes in sense of taste
- Shortness of breath
- Decreased appetite
- Changes in fingernails or toenails
- Swelling of hands, face or feet
- Feeling weak or tired
- Joint and muscle pain
- Nausea and vomiting
- Mouth or lip sores
- Hair loss: in most cases, normal hair growth should return. In some cases (frequency not known) permanent hair loss has been observed
- Redness of the eye, excess tearing
- Skin reactions at the site of Taxotere administration include increased skin pigmentation, redness, tenderness, swelling, warmth and dryness of the skin.
- Tissue damage if Taxotere leaks out of the vein into the tissues
The prescribing information sheet also warns of potentially serious side effects associated with Taxotere, such as acute myeloid leukemia, blood disorders, skin reactions, neurologic symptoms, vision problems, intoxication, and death.
Taxotere Linked to Permanent Hair Loss
Hair loss is a common side effect of chemotherapy treatments. However, the hair usually grows back after treatment ceases. Some patients taking Taxotere have reported that their hair loss became permanent, a condition known as alopecia, and several studies have backed up these claims.
One study in 2006 conducted by the Rocky Mountain Cancer Center found 6.3% of women taking Taxotere for breast cancer had suffered long-term hair loss, described as “male pattern baldness.” Another study published in March 2011 noted that five out of the seven chemotherapy-induced cases of alopecia from a pool of more than 8,000 had been treated with Taxotere.
In a 2012 prospective study of 20 breast cancer chemotherapy patients with alopecia, researchers concluded that “Permanent and severe alopecia is a newly reported complication of the FEC 100–docetaxel breast cancer regimen.”
Victims of a Taxotere lawsuit may be entitled to compensation for their pain and suffering caused by permanent hair loss. Broughton Partners works to connect these Taxotere victims and other victims of negligent drug manufacturers with personal injury law firms.
Thousands of Women File Taxotere Lawsuits
Undergoing treatment and surviving breast cancer is a harrowing experience for most women. But the permanent loss of hair following treatment can be equally as devastating for some.
In 2006, studies were already warning about potential alopecia risks from Taxotere. “Such an emotionally devastating long-term toxicity from this combination must be taken into account when deciding on adjuvant chemotherapy programs for women who likely will be cured of their breast cancer,” one researcher wrote.
This life-altering side effect led thousands of breast cancer survivors and their families to file lawsuits against Sanofi-Aventis, claiming that the manufacturer knew the drug could cause alopecia but failed to warn healthcare professionals or patients of the risk. Patients have also accused Sanofi-Aventis of false marketing.
Taxotere Makers Stand by Taxotere
It wasn’t until December 2015 when the FDA ordered the company to update its warning label to include the risk of permanent hair loss, that more women become aware of its possible side effects.
Even after studies and experts exposed the risks, Sanofi-Aventis insisted there was insufficient evidence. Before being revised, Taxotere’s prescription information sheet stated that once chemotherapy is finished, “hair generally grows back.” While this is true for the majority of women treated with Taxotere, some women will have to deal with the side effects for the rest of their lives.
Because of Sanofi-Aventis’ failure to warn patients of the risks, users of Taxotere who suffer from permanent alopecia may be entitled to compensation for their emotional and physical damage.
Taxotere Settlement Information
So far there has been no global settlement resolving the thousands of cases still pending in U.S. courts, though legal experts say the likelihood of a settlement is increasing. But for a settlement to be reached, several lawsuits may first have to go to trial as test cases. These bellwether trials provide a clearer picture on both sides about the strength of the case. If the verdicts go in favor of the plaintiffs, Sanofi-Aventis will be more likely to settle cases out of court.
Judge Kurt D. Engelhardt of the United States District Court for the Eastern District of Louisiana, where Taxotere cases have been consolidated into multidistrict litigation, has scheduled the first of the bellwether trials for September 2018. Four additional trials are slated for 2019.
Where Are Taxotere Lawsuits Being Filed?
Law firms nationwide are filing Taxotere lawsuits. Cases have been filed by attorneys in the following states:
- New York
- New Jersey
Broughton Partners searches for Taxotere lawsuit leads from all 50 states. The location of a law firm does not matter in drug injury lawsuits such as this. Our unique strategy translates nationwide for both Mass Tort Cases and Local Cases in your area. Our digital processes and 24/7-intake center allows us to operate efficiently no matter where you or your plaintiff is located.
What Claims Are Broughton Partners Reviewing?
Manufacturers of Taxotere such as Sanofi have caused cancer survivors to feel as if they have not made a full recovery due to their permanent hair loss. Victims of this Taxotere lawsuit want to hold the manufacturers of these dangerous drugs responsible for their pain and suffering. Thousands of patients could be entitled to compensation for damages and Broughton Partners wants to help these victims find your law firm.
Our in-take process will be reviewing Taxotere lawsuit leads for the following claims against pharmaceutical companies:
- Failure to provide proper warnings about Taxotere’s side effects
- Was aware of permanent hair loss side effects but continued to sell and market Taxotere
- Failure to properly test Taxotere for potential risks
- Negligent in the design, manufacture, and marketing of Taxotere
- Knowingly sold a defective and dangerous drug
- Did not uphold their duty to create an unreasonably harmful product when used as intended
- Caused permanent hair loss and alopecia among patients
Case Criteria Broughton Partners Looks For
Broughton Partners will only deliver quality Taxotere Lawsuit leads that are pre-qualified and match the case criteria specified by your law firm. Our team of trained specialists will be examining the eligibility of cases and whether or not a patient’s claim qualifies for a Taxotere lawsuit. Our case intake system is built upon unique parameters and algorithms that allow us to dynamically improve case quality and conversion. We do this by running potential plaintiffs through specialized questions and a qualification process based on your law firm’s desired criteria. The Taxotere lawsuit leads that your law firm will receive will be questioned and examined to ensure that they are quality retained plaintiffs.
The Taxotere lawsuit leads that Broughton Partners will deliver must meet the following criteria:
- Potential plaintiffs have taken Taxotere as part of a chemotherapy regimen
- Potential plaintiffs have developed permanent alopecia that was diagnosed by a physician
- Potential plaintiffs clearly have apparent losses as a result of permanent hair loss
Taxotere Lawsuit Leads From Broughton Partners
Our experienced in-house marketing team begins by targeting and connecting with victims that are searching for information about Taxotere and if they have a lawsuit. We then begin tracking Taxotere lawsuit leads online with our industry-leading case-acquisition platform as soon as potential Taxotere plaintiffs show interest or after they call. Our system is constantly being updated and optimized so that only qualified plaintiffs are being delivered to law firms.
Our in-house call center is open and working 24 hours with multi-lingual specialists. Each of our intake associates is highly trained in the legal-intake process and how to handle personal-injury intake sessions with quality and compassion. The Taxotere cases we obtain for you are reviewed by our in-house call center through a customized question and a qualification process that is based on your law firm’s Taxotere case criteria.
When our team finds a qualified Taxotere lawsuit lead, we then gather appropriate case documents that your law firm would need to start working the case right away.
Case-Ready Taxotere Lawsuit Leads
Broughton Partners doesn’t just deliver retained Taxotere plaintiffs, we go further by providing Taxotere lawsuit leads with pre-packaged case documents such as hospital files and product information. We want to save your law firm’s time and give you everything you need to start working the case immediately. The Taxotere lawsuit leads that are provided by Broughton Partners are real victims who have legitimate Taxotere cases.
It can be difficult to find Taxotere lawsuit leads, especially leads that are high-quality with retained claimants. Save time and let us do the tedious work for you by reviewing potential Taxotere lawsuit leads and delivering only the best cases to your law firm.
Broughton Partners Provides Retained Taxotere Lawsuit Plaintiffs to Law Firms
Law firms looking for Taxotere lawsuit cases can work with Broughton Partners to get quality cases that are signed and case-ready. Our attorney case generation services are more than just case leads. We will only deliver Taxotere lawsuit cases that meet the criteria for your acceptance. Broughton Partners can help your firm reach its goals by finding you retained Taxotere plaintiffs that are in need of help today. Spend less time worrying about your legal marketing and let our professionally trained specialists connect your firm with potential Taxotere cases.
Call Broughton Partners today at (855) 463-1735, or contact us for your free consultation. Together we can ensure there is No Claimant without a Claim.
- Drugs.com. “Taxotere”, Drugs.com, https://www.drugs.com/taxotere.html. Accessed April 9, 2018.
- Sanofi. “Taxotere Prescribing Information”, Sanofi.us, http://products.sanofi.us/Taxotere/taxotere.html. Accessed April 9, 2018.
- Palamaras, Loulios MD; Misciali, Cosimo MD; Vincenzi, Colombina MD; Robles, Wanda S. MD, PhD; Tosti, Antonella MD. “Permanent chemotherapy-induced alopecia: A review”, Journal of the American Academy of Dematology, https://www.jaad.org/article/S0190-9622(10)00370-1/fulltext. Accessed April 9, 2018.
- Kluger, N.; Jacot, W.; Frouin, E.; Rigau, V.;l Poujol, S.; Dereure, O.; Guillot, B.; Romieu, G. Bessis, D. “Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients”, Annals of Oncology, https://academic.oup.com/annonc/article/23/11/2879/234091. Accessed April 9, 2018.
- American Cancer Society. “Find Support Programs and Services in Your Area”, American Cancer Society, https://www.cancer.org/treatment/support-programs-and-services.html. Accessed April 9, 2018.